AzTrials
AzTrials

DentalimplantNCT06401200

Radiographic and Clinical Evaluation In Bar

A study testing bar retained implant overdenture in people with Dental, run by Minia University at 1 site in Egypt.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

the aim of this study was to assess the marginal bone loss and soft tissue outcomes of milled and selective laser melted cobalt chromium bar retaining implant mandibular overdenture. Materials and method: twenty completely edentulous patients received new conventional complete dentures. Read more about this study

Who is it for?
Ages 50 to 60 years
Conditions the study is for
Dental
What is being tested?
bar retained implant overdenture
Could I receive a placebo?
No, everyone receives an active treatment
How many people
20 participants
Where
1 siteEgypt
Study dates
15 Nov 2022to 5 Jan 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 50 to 60 years
  • All sexes
  • No healthy volunteers
  • Adult

Who may be able to join

  • completely edentulous patient.
  • age range (50-60) years old.
  • adequate bone volume in canine area bilaterally to receive implant of 3.7 mm diameter and 13mm length verified by CBCT for all patients.
  • sufficient inter arch space (13-14mm) to accommodate bar construction
  • normal maxillo-mandibular relation-ship
  • (Angel's class I)
  • proper oral hygiene

Who cannot join

  • patients with metabolic or systemic disease that may affect osseointegration.
  • history of radiation therapy.
  • history of bisphosphonate intake
  • heavy smoking and bad habits as bruxism.

Trial locations and contacts

1 site in 1 country.

Egypt1 site
  • Minia University

    Minya, Minya Governorate, 61511

Other trials in Egypt

About this study

Official title: Marginal Bone Loss and Soft Tissue Health Around Implants in Selective Laser Melted Versus Milled Cobalt Chromium Bar Retained Mandibular Overdenture:(Randomized Controlled Trial)

the aim of this study was to assess the marginal bone loss and soft tissue outcomes of milled and selective laser melted cobalt chromium bar retaining implant mandibular overdenture. Materials and method: twenty completely edentulous patients received new conventional complete dentures. Two implants were placed at mandibular canine areas, patients were randomly allocated into two equal groups: milled co-cr bar group and selective laser melted bar group. Marginal bone loss, modified plaque index (mPI), probing depth (PD) and modified gingival index (mGI) were evaluated at base line, 6 and 12 months follow up visits.

Read the detailed description

Materials and method: twenty completely edentulous patients received new conventional complete dentures. Two implants were placed at mandibular canine areas, patients were randomly allocated into two equal groups: milled co-cr bar group and selective laser melted bar group. Marginal bone loss, modified plaque index (mPI), probing depth (PD) and modified gingival index (mGI) were evaluated at base line, 6 and 12 months follow up visits.

Conditions
Dental
Being tested
bar retained implant overdenture
Keywords
SLM, Milled, Bar overdenture

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • bar retained implant overdentureOther

    Also called bar attachment implant mandibular overdenture

    use of bar attachment in completely edentulous patient

Study groups in NCT06401200
Study groupRoleWhat they receive
group 1: milled cobalt chromium barActive comparator10 completely edentulous patients received two implants at canine region bilaterally (3.7mm diameter- 13mm length), within two weeks after surgery (following early loading protocol), an open tray impression technique was made for bar construction which was designed according to randomization patient enrollment
Receives: Other: bar retained implant overdenture
group 2: Selective laser melted cobalt chromium barExperimental10 completely edentulous patients received two implants at canine region bilaterally (3.7mm diameter- 13mm length), within two weeks after surgery (following early loading protocol), an open tray impression technique was made for bar construction which was designed according to randomization patient enrollment
Receives: Other: bar retained implant overdenture

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Radiographic Evaluation (Vertical Marginal bone loss in millimeters)

    using periapical x-ray with parallel long cone technique from implant shoulder till bony crest

    Measured: at 6 and 12 months

Secondary outcomes (3)
  1. Probing depth in millimeters.

    using sensitive pressure plastic probe in four sites mesial, distal, buccal and lingual

    Measured: at 0,6 and 12 months

  2. modified Plaque Index.

    using Mombelli charting scale at four aspects (mesial, distal, buccal and lingual)

    Measured: at 0,6 and 12 months follow up

  3. modified Gingival Index

    using Apsi charting scale at four sites (mesial, distal, buccal and lingual)

    Measured: at base line, 6 and 12 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted6 May 2024
  2. Study start15 Nov 2022
  3. Primary completion27 Dec 2023
  4. Study completion5 Jan 2024

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Health services research
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Participant
Enrolment
20 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06401200
Sponsor's protocol ID
636
Other IDs
Iman Adel Asfahani, Hussein Abd Elhady
Acronym
implant
Status last verified
May 2024
First submitted
30 Apr 2024
Last updated
9 May 2024
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Publications

  • El-Asfahani IA, Abd El-Moatty R, Mohamed GF, Hussein HA. Marginal bone loss and soft tissue health around two-implant mandibular overdenture retained with milled versus selective laser melted cobalt chromium bar: a randomized clinical trial. BMC Oral Health. 2024 Oct 4;24(1):1180. doi: 10.1186/s12903-024-04883-6.

    PubMed 39367394

Questions about this trial

What is this clinical trial studying?

A study testing bar retained implant overdenture in people with Dental, run by Minia University at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 7 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 9 May 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Radiographic Evaluation (Vertical Marginal bone loss in millimeters) (time frame: at 6 and 12 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT06401200, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 9 May 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in